LambdaVision, a biotech innovator, has closed a $7M seed funding round towards leveraging microgravity to manufacture its investigational protein-based artificial retina to help patients regain sight lost to retinal degenerative diseases
Seven Seven Six and Aurelia Foundry Fund co-led the seed round with additional support from Seraphim Space, providing the company runway into 2027






